Therapy Areas: Autoimmune
18 April 2018 - Biotechnology company Rigel Pharmaceuticals Inc (Nasdaq:RIGL) revealed on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for TAVALISSE for the treatment...
13 April 2018 - United States-based Mylan has acquired an exclusive license to commercialise a biosimilar to Humira (adalimumab), developed by Fujifilm Kyowa Kirin Biologics, in Europe, it was reporte...
11 April 2018 - - Cambridge, Massachusetts-based biotechnology company Magenta Therapeutics Inc. has completed a USD 52m Series C financing, the company said.
Proceeds from the financing will be...
11 April 2018 - - Minneapolis, Minnesota-based cellular therapies developers partner Be The Match BioTherapies has made its second equity investment in Cambridge, Massachusetts-based biotechnology com...
11 April 2018 - - Florham Park, New Jersey-based clinical-stage biopharmaceutical company Protalex, Inc. (OTCQB: PRTX) has enrolled the first of three patients in cohort four of its US/UK Phase 1/2 tr...
10 April 2018 - The Scottish Medicines Consortium (SMC) has approved funding for four new therapies to be made available via NHS Scotland, Pharma Times reported on Tuesday.Shire's (LON: SHP) Reve...